Cargando…

Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT

AIMS/HYPOTHESIS: Using variable diabetic retinopathy screening intervals, informed by personal risk levels, offers improved engagement of people with diabetes and reallocation of resources to high-risk groups, while addressing the increasing prevalence of diabetes. However, safety data on extending...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broadbent, Deborah M., Wang, Amu, Cheyne, Christopher P., James, Marilyn, Lathe, James, Stratton, Irene M., Roberts, John, Moitt, Tracy, Vora, Jiten P., Gabbay, Mark, García-Fiñana, Marta, Harding, Simon P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716929/ https://www.ncbi.nlm.nih.gov/pubmed/33146763 http://dx.doi.org/10.1007/s00125-020-05313-2

Ejemplares similares

Individualised screening for diabetic retinopathy: the ISDR study—rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening
por: Broadbent, Deborah M, et al.
Publicado: (2019)

Introducing personalised risk based intervals in screening for diabetic retinopathy: development, implementation and assessment of safety, cost-effectiveness and patient experience (ISDR): a case study in the use of automated systems in trials
por: Appelbe, Duncan, et al.
Publicado: (2015)

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
por: Eleuteri, Antonio, et al.
Publicado: (2017)

Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules
por: García‐Fiñana, Marta, et al.
Publicado: (2018)

Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis
por: Sampson, Christopher J, et al.
Publicado: (2015)

First Prospective Cohort Study of Diabetic Retinopathy from Sub-Saharan Africa: High Incidence and Progression of Retinopathy and Relationship to Human Immunodeficiency Virus Infection
por: Burgess, Philip I., et al.
Publicado: (2016)

Personalising screening of sight-threatening diabetic retinopathy - qualitative evidence to inform effective implementation
por: Byrne, P., et al.
Publicado: (2020)

High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention
por: Burgess, P I, et al.
Publicado: (2014)

Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs
por: Lund, S H, et al.
Publicado: (2016)

Individualised treatment of proliferative diabetic retinopathy: optimal surgical timing improves long-term outcomes
por: Zenoni, Stefano, et al.
Publicado: (2010)

Individualising treatment choices in a crowded treatment algorithm
por: Fisher, Rosalie, et al.
Publicado: (2013)

Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma
por: Willowson, Kathy P., et al.
Publicado: (2021)

Non-equivalence of anti-Müllerian hormone automated assays—clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing
por: Iliodromiti, Stamatina, et al.
Publicado: (2017)

Incidence and progression of diabetic retinopathy in Sub-Saharan Africa: A five year cohort study
por: Burgess, Philip I., et al.
Publicado: (2017)

Gynaecomastia Surgery: Should it be Individualised?
por: Ghnnam, Wagih Mommataz
Publicado: (2014)

Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs
por: Paolucci, Stefania, et al.
Publicado: (2020)

Active Children Through Individual Vouchers Evaluation: A Mixed-Method RCT
por: James, Michaela L., et al.
Publicado: (2020)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Towards individualisation of treatment in endometrial cancer
por: Taylor, S E, et al.
Publicado: (2012)

Individualised aspiration dynamics: Calculation by proofs
por: Wu, Bin, et al.
Publicado: (2018)

Short Report: Complications Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy
por: Scanlon, P H, et al.
Publicado: (2014)

Individualised Exercise Training Enhances Antioxidant Buffering Capacity in Idiopathic Pulmonary Fibrosis
por: Wallis, Tim J. M., et al.
Publicado: (2023)

Doctors’ understanding of individualisation of drug treatments: a qualitative interview study
por: Denford, S, et al.
Publicado: (2013)

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
por: Pushpakom, Sudeep P, et al.
Publicado: (2015)

Switching to a 'nuke-sparing' raltegravir/atazanavir combination: an individualised approach
por: Grant, A, et al.
Publicado: (2010)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

Enabling individualised health in learning healthcare systems
por: Wongvibulsin, Shannon, et al.
Publicado: (2020)

Individualised prescription of medications for treatment of obesity in adults
por: Hocking, Samantha, et al.
Publicado: (2023)

Individualisation of drug treatments for patients with long-term conditions: a review of concepts
por: Denford, S, et al.
Publicado: (2014)

Adapting the randomised controlled trial (RCT) for precision medicine: introducing the nested-precision RCT (npRCT)
por: Kappelmann, Nils, et al.
Publicado: (2021)

An equivalent circuit model for onset and offset exercise response
por: Zhang, Yi, et al.
Publicado: (2014)

Winter is over: The use of Artificial Intelligence to individualise radiation therapy for breast cancer()
por: Poortmans, Philip M.P., et al.
Publicado: (2019)

The conundrum of iron in multiple sclerosis – time for an individualised approach
por: van Rensburg, Susan J., et al.
Publicado: (2012)

The Individualised versus the Public Health Approach to Treating Ebola
por: Boyles, Tom H.
Publicado: (2015)

Towards Multidimensional Radiotherapy: Key Challenges for Treatment Individualisation
por: Toma-Dasu, Iuliana, et al.
Publicado: (2015)

Individualised Responsible Artificial Intelligence for Home-Based Rehabilitation
por: Vourganas, Ioannis, et al.
Publicado: (2020)

Oral health indices predict individualised recall interval
por: Haukka, Anna, et al.
Publicado: (2020)

Tracking the contribution of inductive bias to individualised internal models
por: Török, Balázs, et al.
Publicado: (2022)

WHO next‐generation partograph: revolutionary steps towards individualised labour care
por: Hofmeyr, GJ, et al.
Publicado: (2021)

Bathing adaptations in the homes of older adults (BATH-OUT): protocol for a feasibility randomised controlled trial (RCT)
por: Whitehead, Phillip J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uqmcej53un4oshusvkp71i8ao8